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The Role of HO-1 in Cardiovascular Disease
Hemoxygenase-1 (HO-1) is the rate-controlling enzyme for the degradation ofheme into iron, carbon monoxide, and biliverdin, which is subsequently con-
verted into bilirubin. This review article provides an overview of the biochemistry,
physiology, and pathophysiology of HO-1 as it relates to cardiovascular diseases.
Hypothesized effects include anti-inflammatory, anti-apoptotic, and angiogenic ac-
tions. Some of these actions are attributable to the release of carbon monoxide, which
may mimic some of the effects of nitric oxide, and/or bilirubin, which is a natural
antioxidant. The physiological induction of HO-1 may be an adaptive response to
several noxious stimuli that may be a target for manipulation. See page 971.
Page 982
Myocardial Infarction
Obese Suffer MIs at a Younger Age
Madala and colleagues hypothesized that obesity would be associated with myo-cardial infarction (MI) at younger ages. TheCRUSADE registrywas retrospec-
tively examined to study the relationship between body mass index (BMI) and age of
first MI. The age of first MI decreased with higher BMIs; compared with those with
BMIs 25 kg/m2, those with BMI 40 kg/m2 were 12 years younger. These data
suggest that as the obesity pandemic worsens, MI may occur at increasingly younger
ages. See page 979. See figure.
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Page 1000
Heart Failure
Prognostic Value of Changes in NT-proBNP
Massonand colleagues assessed the prognostic value of repeateddeterminations ofN-terminal pro-brain natriuretic peptide (NT-proBNP) in subjects enrolled in
VAL-HeFT who had chronic heart failure. The NT-proBNP level at 4 months was
slightly better at predicting mortality than the baseline level. Changes in the level,
whether calculated as absolute or relative changes, were less accurate than absolute
levels, but did add additional information especially when considered in broad catego-
ries such as high or low. Serial determinations of NT-proBNP may improve risk
stratification for patientswith stable heart failure comparedwith a singlemeasurement.
See page 997. See figure.
Page 1011
Myocardial Metabolism
Caloric Restriction Decreases Myocardial TGs and Improves Myocardial Stiffness
Triglycerides (TGs) accumulate in the heart when myocardial fatty acid uptakeexceeds the amountused for oxidation to generate energy. In animal experiments,
increasedmyocardial TGs are associatedwith impairedmyocardial function.Hammer
and colleagues studied the effect of 16 weeks of caloric restriction on myocardial TGs
in obese patients with type 2 diabetes mellitus. Caloric restriction decreased body
weight by 8 kg and was associated with improved glucoregulation, a decrease in
myocardial TG content, and improvements in diastolic function. This study demon-
strates thatmyocardialTGstores canbe reducedby caloric restriction and that thismay
improve myocardial stiffness. See page 1006. See figure.
